Ameriprise Financial Inc Incyte Corp Transaction History

Ameriprise Financial Inc

$381 Billion
Q3 2024

A detailed history of Ameriprise Financial Inc transactions in Incyte Corp stock. As of the latest transaction made, Ameriprise Financial Inc holds 742,992 shares of INCY stock, worth $53.4 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

742,992

Previous 767,073 3.14%

Holding current value

$53.4 Million

Previous $46.5 Million 5.62%

% of portfolio

0.01%

Previous 0.01%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$57.33 - $68.61 $1.38 Million - $1.65 Million	-24,081 Reduced 3.14%	742,992 $49.1 Million
Q2 2024 Aug 14, 2024	SELL	$51.18 - $63.75 $4.58 Million - $5.7 Million	-89,472 Reduced 10.45%	767,073 $46.5 Million
Q1 2024 May 15, 2024	SELL	$56.55 - $66.59 $1.96 Million - $2.31 Million	-34,654 Reduced 3.89%	856,545 $48.8 Million
Q4 2023 Feb 14, 2024	SELL	$52.16 - $64.19 $2.13 Million - $2.62 Million	-40,767 Reduced 4.37%	891,199 $56 Million
Q3 2023 Nov 14, 2023	BUY	$57.77 - $65.93 $13.3 Million - $15.2 Million	231,046 Added 32.96%	931,966 $53.8 Million
Q2 2023 Aug 14, 2023	BUY	$60.95 - $75.51 $5.61 Million - $6.95 Million	92,008 Added 15.11%	700,920 $43.6 Million
Q1 2023 May 15, 2023	BUY	$70.23 - $86.01 $23.3 Million - $28.5 Million	331,283 Added 119.33%	608,912 $44 Million
Q4 2022 Feb 14, 2023	BUY	$67.18 - $84.11 $3.17 Million - $3.96 Million	47,134 Added 20.45%	277,629 $22.3 Million
Q3 2022 Nov 14, 2022	SELL	$66.18 - $82.86 $598,664 - $749,551	-9,046 Reduced 3.78%	230,495 $15.4 Million
Q2 2022 Aug 15, 2022	SELL	$66.18 - $83.18 $591,384 - $743,296	-8,936 Reduced 3.6%	239,541 $18.2 Million
Q1 2022 May 16, 2022	BUY	$66.02 - $79.71 $2.97 Million - $3.58 Million	44,934 Added 22.08%	248,477 $19.7 Million
Q4 2021 Feb 14, 2022	BUY	$63.34 - $74.11 $10.2 Million - $12 Million	161,289 Added 381.71%	203,543 $14.9 Million
Q3 2021 Nov 15, 2021	SELL	$68.67 - $84.02 $380,569 - $465,638	-5,542 Reduced 11.6%	42,254 $2.91 Million
Q2 2021 Aug 16, 2021	SELL	$79.87 - $87.53 $5.01 Million - $5.49 Million	-62,721 Reduced 56.75%	47,796 $4.02 Million
Q1 2021 May 17, 2021	SELL	$76.02 - $100.5 $862,598 - $1.14 Million	-11,347 Reduced 9.31%	110,517 $8.98 Million
Q4 2020 Feb 12, 2021	SELL	$80.74 - $97.7 $1.06 Million - $1.29 Million	-13,154 Reduced 9.74%	121,864 $10.6 Million
Q3 2020 Nov 16, 2020	BUY	$85.07 - $109.69 $6.7 Million - $8.64 Million	78,772 Added 140.05%	135,018 $12.1 Million
Q2 2020 Aug 14, 2020	SELL	$74.18 - $108.93 $16.7 Million - $24.5 Million	-225,108 Reduced 80.01%	56,246 $5.85 Million
Q1 2020 May 15, 2020	SELL	$63.18 - $85.97 $5.36 Million - $7.29 Million	-84,843 Reduced 23.17%	281,354 $20.6 Million
Q4 2019 Feb 14, 2020	BUY	$73.04 - $95.72 $8.14 Million - $10.7 Million	111,395 Added 43.72%	366,197 $32 Million
Q3 2019 Nov 14, 2019	BUY	$72.82 - $86.52 $9.82 Million - $11.7 Million	134,868 Added 112.45%	254,802 $18.9 Million
Q2 2019 Aug 14, 2019	BUY	$73.52 - $88.7 $3.8 Million - $4.58 Million	51,649 Added 75.64%	119,934 $10.2 Million
Q1 2019 May 15, 2019	BUY	$63.56 - $88.17 $878,526 - $1.22 Million	13,822 Added 25.38%	68,285 $5.88 Million
Q4 2018 Feb 14, 2019	BUY	$58.5 - $69.94 $83,772 - $100,154	1,432 Added 2.7%	54,463 $3.46 Million
Q3 2018 Nov 14, 2018	SELL	$61.75 - $74.23 $1.1 Million - $1.32 Million	-17,762 Reduced 25.09%	53,031 $3.66 Million
Q2 2018 Aug 14, 2018	BUY	$60.85 - $83.98 $468,058 - $645,974	7,692 Added 12.19%	70,793 $4.74 Million
Q1 2018 May 15, 2018	SELL	$83.06 - $100.98 $11.8 Million - $14.3 Million	-141,570 Reduced 69.17%	63,101 $5.26 Million
Q4 2017 Feb 12, 2018	SELL	$93.56 - $116.6 $402,401 - $501,496	-4,301 Reduced 2.06%	204,671 $19.4 Million
Q3 2017 Nov 07, 2017	BUY	$109.15 - $138.27 $22.8 Million - $28.9 Million	208,972	208,972 $24.4 Million

Others Institutions Holding INCY

# of Institutions

645

Shares Held

186M

Call Options Held

714K

Put Options Held

557K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account

Ameriprise Financial Inc Incyte Corp Transaction History